amodiaquine has been researched along with Ebola Hemorrhagic Fever in 5 studies
Amodiaquine: A 4-aminoquinoline compound with anti-inflammatory properties.
amodiaquine : A quinoline having a chloro group at the 7-position and an aryl amino group at the 4-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We fit unadjusted and adjusted regression models to standardized patient-level data to estimate the risk ratio for death among patients with confirmed EVD who were prescribed artesunate-amodiaquine (artesunate-amodiaquine group), as compared with those who were prescribed artemether-lumefantrine (artemether-lumefantrine group) and those who were not prescribed any antimalarial drug (no-antimalarial group)." | 3.83 | Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease. ( Azman, AS; Azuma, P; Bocquin, A; Cabrol, JC; Cannas, A; Ciglenecki, I; de Smet, M; Gignoux, E; Job, D; Kurth, A; Logue, C; Massaquoi, M; Petrucci, R; Potet, J; Pottage, T; Serafini, M; Sterk, E; Strecker, T; Suzuki, M; Tiffany, A; Yue, C, 2016) |
| "Management of Ebola virus disease (EVD) has historically focused on infection prevention, case detection and supportive care." | 2.61 | Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. ( Adhikari, NKJ; Bah, EI; Chan, A; Fowler, RA; Hajek, J; Kao, R; Kiiza, P; Kwon, HY; Lamah, MC; Lamontagne, F; Lee, JS; Mishra, S; Murthy, S; Siemieniuk, R; Teo, K, 2019) |
| "Amodiaquine is a widely used antimalarial in the countries that experience outbreaks of EVD and, therefore, holds promise as an approved drug that could be repurposed for treating EBOV infections." | 1.51 | In Vivo Activity of Amodiaquine against Ebola Virus Infection. ( DeWald, LE; Dowling, WE; Dyall, J; Eakin, AE; Gahagen, J; Gerhardt, DM; Green, CE; Hensley, LE; Holbrook, MR; Honko, AN; Huzella, L; Jahrling, PB; Janosko, K; Johnson, JC; Mirsalis, JC; Osborn, BL; Postnikova, E; Tang, L; Torzewski, LM, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Selaković, Ž | 1 |
| Tran, JP | 1 |
| Kota, KP | 1 |
| Lazić, M | 1 |
| Retterer, C | 1 |
| Besch, R | 1 |
| Panchal, RG | 1 |
| Soloveva, V | 1 |
| Sean, VA | 1 |
| Jay, WB | 1 |
| Pavić, A | 1 |
| Verbić, T | 1 |
| Vasiljević, B | 1 |
| Kuehl, K | 1 |
| Duplantier, AJ | 1 |
| Bavari, S | 1 |
| Mudhasani, R | 1 |
| Šolaja, BA | 1 |
| DeWald, LE | 1 |
| Johnson, JC | 1 |
| Gerhardt, DM | 1 |
| Torzewski, LM | 1 |
| Postnikova, E | 1 |
| Honko, AN | 1 |
| Janosko, K | 1 |
| Huzella, L | 1 |
| Dowling, WE | 1 |
| Eakin, AE | 1 |
| Osborn, BL | 1 |
| Gahagen, J | 1 |
| Tang, L | 1 |
| Green, CE | 1 |
| Mirsalis, JC | 1 |
| Holbrook, MR | 1 |
| Jahrling, PB | 1 |
| Dyall, J | 1 |
| Hensley, LE | 1 |
| Lee, JS | 1 |
| Adhikari, NKJ | 1 |
| Kwon, HY | 1 |
| Teo, K | 1 |
| Siemieniuk, R | 1 |
| Lamontagne, F | 1 |
| Chan, A | 1 |
| Mishra, S | 1 |
| Murthy, S | 1 |
| Kiiza, P | 1 |
| Hajek, J | 1 |
| Bah, EI | 1 |
| Lamah, MC | 1 |
| Kao, R | 1 |
| Fowler, RA | 1 |
| Gignoux, E | 1 |
| Azman, AS | 1 |
| de Smet, M | 1 |
| Azuma, P | 1 |
| Massaquoi, M | 1 |
| Job, D | 1 |
| Tiffany, A | 1 |
| Petrucci, R | 1 |
| Sterk, E | 1 |
| Potet, J | 1 |
| Suzuki, M | 1 |
| Kurth, A | 1 |
| Cannas, A | 1 |
| Bocquin, A | 1 |
| Strecker, T | 1 |
| Logue, C | 1 |
| Pottage, T | 1 |
| Yue, C | 1 |
| Cabrol, JC | 1 |
| Serafini, M | 1 |
| Ciglenecki, I | 1 |
| Aregawi, M | 1 |
| Smith, SJ | 1 |
| Sillah-Kanu, M | 1 |
| Seppeh, J | 1 |
| Kamara, AR | 1 |
| Williams, RO | 1 |
| Aponte, JJ | 1 |
| Bosman, A | 1 |
| Alonso, P | 1 |
1 review available for amodiaquine and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review.
Topics: Amides; Amodiaquine; Antibodies, Monoclonal; Antiviral Agents; Artemisinins; Databases, Factual; Dru | 2019 |
4 other studies available for amodiaquine and Ebola Hemorrhagic Fever
| Article | Year |
|---|---|
Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Topics: Animals; Antiviral Agents; Chrysenes; Ebolavirus; Hemorrhagic Fever, Ebola; Lysosomes; Mice; Surface | 2019 |
In Vivo Activity of Amodiaquine against Ebola Virus Infection.
Topics: Amodiaquine; Animals; Antiviral Agents; Artemisinins; Disease Models, Animal; Drug Combinations; Fem | 2019 |
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
Topics: Adolescent; Adult; Amodiaquine; Anti-Bacterial Agents; Antimalarials; Artemether, Lumefantrine Drug | 2016 |
Impact of the Mass Drug Administration for malaria in response to the Ebola outbreak in Sierra Leone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amodiaquine; Antimalarials; Artemisinins; Child; Child, | 2016 |